ReSTOR Implantable Intraocular Lens - Throw Your Reading Glasses Away!
AcrySof® ReSTOR® has been uniquely designed to improve vision at all distances, giving cataract patients their best chance ever to live free of glasses and avoid cataract surgery.
The FDA-approved ReSTOR lens is manufactured by Alcon Surgical, one of the leading optics manufacturers in the United States for over 50 years. AcrySof, the material used to make the ReSTOR IOL, has already been used in another IOL and implanted millions of times since the early 1990’s.
AcrySof® lenses were the first to utilize foldable material specifically designed for use in the human eye as an IOL. Due to their excellent safety and effectiveness profile, they have become the most frequently implanted lenses in cataract procedures worldwide.
As with Crystalens, Refractive Lensectomy addresses the underlying problem with presbyopia (which causes the need for reading glasses) by replacing the existing crystalline lens with the multifocal ReSTOR. The ReSTOR does not depend on contraction of the ciliary muscle to move the lens to create a range of vision.
Instead, the ReSTOR lens has a very small (3.6mm) diffractive region that facilitates both near and distance vision. Through a series of 12 tiny steps which gradually blends into the outer (refractive) portion of the lens, "apodization" creates a smooth transition of light to multiple focal points.
In normal lighting conditions, the apodized diffractive portion of the ReSTOR lens sends optimal light to both near and distance focal points, providing a full range of quality vision. In dimly lit conditions the refractive portion sends greater light energy to the distant focal point for enhanced distance vision.
The FDA trial results showed 80 percent of ReSTOR patients NEVER needed glasses following surgery. This is the highest level of freedom from glasses ever demonstrated in an IOL clinical trial.
The ReSTOR provided excellent near and distance vision - and very good intermediate vision - compared with conventional monofocal intraocular lens (IOLs). Previously, cataract patients received a monofocal - or single focus - lens that required some type of glasses.
In an independent study in which ReSTOR was compared to the Array TM IOL and monofocal IOL in terms of reading performance (whether they could read paragraphs of decreasing size). Four of five ReSTOR patients were able to read small type at 20/16. Only one in 7 Array patients was able to read small type at 20/16. And none of the multifocal patients were able to read small type at 20/16.
Most importantly, 94 percent of patients who received the ReSTOR lens were so satisfied with their new vision they would have the procedure again.
|